Clinical trial

BKM120 in Cancers With PIK3CA Activating Mutations

NCT01501604

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2012-01-01

PhasePHASE2

Study timeline

Study start (unknown)2012-01-01Date precision: month

Registry last updated2015-09-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerverified · MONDO: lung cancer

Breast Cancerverified · MONDO: breast cancer

Colorectal Cancerverified · MONDO: colorectal cancer

Cholangiocarcinomaverified · MONDO: cholangiocarcinoma

Solid Tumorsunresolved

Interventions

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

Novartis Pharmaceuticalscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01501604 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.